Evidence map›Paper›PMID 29242835›Full record

ArticlemSphere

Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics.

Kelly M Hines, Adam Waalkes, Kelsi Penewit, Elizabeth A Holmes, Stephen J Salipante, Brian J Werth, Libin Xu

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. mBio · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. DefectivemSphere · 2024
    Article
  18. Article
  19. Article
  20. Rising prevalence and drug resistance ofFrontiers in cellular and infection microbiology · 2024
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kelly M HinesDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-9125-5268
Adam WaalkesDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Kelsi PenewitDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Elizabeth A HolmesDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Stephen J SalipanteDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Brian J WerthDepartment of Pharmacy, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-6751-4098
Libin XuDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-1021-5200
University of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous work suggests that altered lipid metabolism may be associated with daptomycin resistance in Gram-positive pathogens, but lipidomic changes underlying resistance are not fully understood. We performed untargeted lipidomics by using three-dimensional hydrophilic interaction liquid chromatography-ion mobility-mass spectrometry (HILIC-IM-MS) to characterize alterations in the lipidomes of daptomycin-susceptible and -resistant isogenic strain pairs of

Indexed as

antibiotic resistancedaptomycinGram-positive bacteriaion mobility-mass spectrometrylipidomicsPgsAwhole-genome sequencing

Identifiers

PMID29242835
PMCPMC5729219
OpenAlexW2772917808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.